OR WAIT null SECS
Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled-release pellets for one of its products.
CDMO Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled-release pellets for one of its products. As part of the five-year supply agreement, Saneca Pharma will be investing in its facility in Hlohovec, Slovakia, to increase its capacity for wurster coating of the pellets. The pellets are made by extrusion spheronization. The CDMO’s technology will be used to produce enteric-coated pellets that prevent dissolution in the stomach, while allowing dissolution in the small intestine.
Saneca Pharma has demonstrated its pellet manufacturing capabilities to Menarini using 100-kg batch sizes. Following the investment at its plant, the CDMO will be able to handle significantly larger batch sizes.
Based in western Slovakia, with close proximity to Vienna, Saneca Pharma develops and manufactures a range of finished dosage forms. It has capabilities in solids and semisolids and specialist expertise in the development of opiate APIs and final dosage forms from farm to pharmacy.
Source: Saneca Pharma